First Hawaiian Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Hold
7,742
0.25% 39
2026
Q1
$1.68M Hold
7,742
0.24% 42
2025
Q4
$1.77M Sell
7,742
-201
-3% -$45.8K 0.24% 44
2025
Q3
$1.84M Buy
7,943
+387
+5% +$78.8K 0.24% 45
2025
Q2
$1.4M Buy
7,556
+60
+0.8% +$11.2K 0.19% 51
2025
Q1
$1.57M Sell
7,496
-27,445
-79% -$5.34M 0.23% 47
2024
Q4
$6.21M Buy
34,941
+996
+3% +$183K 0.2% 61
2024
Q3
$6.7M Buy
33,945
+1,846
+6% +$345K 0.21% 59
2024
Q2
$5.51M Buy
32,099
+2,657
+9% +$440K 0.19% 68
2024
Q1
$5.36M Sell
29,442
-3,335
-10% -$575K 0.17% 75
2023
Q4
$5.08M Sell
32,777
-5,928
-15% -$864K 0.16% 78
2023
Q3
$5.77M Sell
38,705
-172
-0.4% -$25.3K 0.2% 61
2023
Q2
$5.24M Sell
38,877
-969
-2% -$142K 0.17% 67
2023
Q1
$6.35M Sell
39,846
-541
-1% -$82.7K 0.22% 51
2022
Q4
$6.53M Sell
40,387
-2,811
-7% -$431K 0.24% 50
2022
Q3
$5.8M Sell
43,198
-1,836
-4% -$263K 0.23% 50
2022
Q2
$6.9M Sell
45,034
-3,781
-8% -$578K 0.25% 45
2022
Q1
$7.91M Sell
48,815
-2,452
-5% -$356K 0.25% 46
2021
Q4
$6.94M Buy
51,267
+2,255
+5% +$266K 0.2% 54
2021
Q3
$5.29M Buy
49,012
+734
+2% +$83.9K 0.22% 53
2021
Q2
$5.44M Sell
48,278
-3,180
-6% -$358K 0.23% 53
2021
Q1
$5.57M Sell
51,458
-169
-0.3% -$18.1K 0.24% 52
2020
Q4
$5.53M Buy
51,627
+1,153
+2% +$111K 0.25% 50
2020
Q3
$4.42M Buy
50,474
+584
+1% +$55K 0.23% 56
2020
Q2
$4.9M Buy
49,890
+172
+0.3% +$15.1K 0.26% 52
2020
Q1
$3.79M Sell
49,718
-207
-0.4% -$17.6K 0.23% 54
2019
Q4
$4.42M Sell
49,925
-1,608
-3% -$133K 0.21% 58
2019
Q3
$3.9M Buy
51,533
+6,385
+14% +$438K 0.2% 67
2019
Q2
$3.28M Buy
45,148
+7,529
+20% +$592K 0.18% 77
2019
Q1
$3.03M Buy
37,619
+7,907
+27% +$647K 0.16% 84
2018
Q4
$2.74M Sell
29,712
-820
-3% -$72.1K 0.16% 85
2018
Q3
$2.89M Buy
30,532
+19,416
+175% +$1.84M 0.15% 95
2018
Q2
$1.03M Buy
11,116
+800
+8% +$78.1K 0.13% 49
2018
Q1
$976K Hold
10,316
0.13% 49
2017
Q4
$998K Sell
10,316
-81
-0.8% -$7.63K 0.13% 50
2017
Q3
$924K Sell
10,397
-396
-4% -$30.1K 0.12% 49
2017
Q2
$783K Sell
10,793
-333
-3% -$22.4K 0.11% 50
2017
Q1
$725K Buy
11,126
+226
+2% +$14.2K 0.11% 44
2016
Q4
$682K Sell
10,900
-288
-3% -$17.6K 0.11% 44
2016
Q3
$707K Sell
11,188
-894
-7% -$57.9K 0.12% 45
2016
Q2
$748K Sell
12,082
-458
-4% -$27.9K 0.13% 45
2016
Q1
$716K Buy
12,540
+926
+8% +$51.6K 0.12% 42
2015
Q4
$688K Sell
11,614
-21
-0.2% -$1.21K 0.12% 41
2015
Q3
$633K Sell
11,635
-591
-5% -$38.5K 0.11% 40
2015
Q2
$821K Sell
12,226
-594
-5% -$38.8K 0.13% 36
2015
Q1
$750K Buy
12,820
+398
+3% +$24K 0.12% 43
2014
Q4
$813K Sell
12,422
-560
-4% -$35.3K 0.13% 41
2014
Q3
$750K Sell
12,982
-291
-2% -$16.2K 0.13% 45
2014
Q2
$749K Buy
13,273
+940
+8% +$49.3K 0.13% 44
2014
Q1
$633K Sell
12,333
-1,088
-8% -$55K 0.11% 50
2013
Q4
$708K Sell
13,421
-854
-6% -$42K 0.13% 47
2013
Q3
$639K Buy
14,275
+417
+3% +$18.5K 0.13% 49
2013
Q2
$573K Buy
+13,858
New +$606K 0.12% 55

Other funds holding ABBV

First Hawaiian Bank's ABBV Position: Q2 2026 in Review

First Hawaiian Bank held its AbbVie (ABBV) position steady in Q2 2026 at 7,742 shares worth $1.95M. The position accounts for 0.25% of the portfolio, ranked #39.

First Hawaiian Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.91M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Hawaiian Bank held 7,742 shares of AbbVie worth $1.95M as of Q2 2026.
  • First Hawaiian Bank left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.25% of First Hawaiian Bank's portfolio in Q2 2026, its #39 holding.
  • First Hawaiian Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • First Hawaiian Bank's AbbVie position peaked at $7.91M in Q1 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Hawaiian Bank's 13F filing for Q2 2026, filed 13 Jul 2026.